Dual Suppression of the Cyclin-Dependent Kinase Inhibitors CDKN2C and CDKN1A in Human Melanoma

Resistance to BRAF(V600E) inhibitors is associated with reactivation of mitogen-activated protein kinase (MAPK) signaling at different levels in melanoma. To identify downstream effectors of MAPK signaling that could be used as potential additional therapeutic targets for BRAF(V600E) inhibitors, we...

Descripción completa

Detalles Bibliográficos
Autores principales: Jalili, Ahmad, Wagner, Christine, Pashenkov, Mikhail, Pathria, Gaurav, Mertz, Kirsten D., Widlund, Hans R., Lupien, Mathieu, Brunet, Jean- Philippe, Golub, Todd R., Stingl, Georg, Fisher, David E., Ramaswamy, Sridhar, Wagner, Stephan N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2012
Materias:
Brief Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3490842/
https://www.ncbi.nlm.nih.gov/pubmed/22997239
http://dx.doi.org/10.1093/jnci/djs373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3490842/
https://www.ncbi.nlm.nih.gov/pubmed/22997239
http://dx.doi.org/10.1093/jnci/djs373

Ejemplares similares